EGX: NIPH Statistics

Total Valuation

EI- Nile Co. for Pharmaceuticals and Chemical Industries has a market cap or net worth of EGP 565.28 million. The enterprise value is 1.05 billion.

Market Cap	565.28M
Enterprise Value	1.05B

Important Dates

The last earnings date was Wednesday, November 27, 2024.

Earnings Date	Nov 27, 2024
Ex-Dividend Date	Nov 19, 2024

Share Statistics

EI- Nile Co. for Pharmaceuticals and Chemical Industries has 10.13 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	10.13M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	4.95%
Owned by Institutions (%)	n/a
Float	2.15M

Valuation Ratios

The trailing PE ratio is 22.94.

PE Ratio	22.94
Forward PE	n/a
PS Ratio	0.64
PB Ratio	1.24
P/TBV Ratio	1.24
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.45, with an EV/FCF ratio of -4.11.

EV / Earnings	42.72
EV / Sales	1.19
EV / EBITDA	12.45
EV / EBIT	14.25
EV / FCF	-4.11

Financial Position

The company has a current ratio of 1.10, with a Debt / Equity ratio of 1.11.

Current Ratio	1.10
Quick Ratio	0.28
Debt / Equity	1.11
Debt / EBITDA	5.98
Debt / FCF	-1.97
Interest Coverage	2.90

Financial Efficiency

Return on equity (ROE) is 4.98% and return on invested capital (ROIC) is 5.53%.

Return on Equity (ROE)	4.98%
Return on Assets (ROA)	3.45%
Return on Capital (ROIC)	5.53%
Revenue Per Employee	354,249
Profits Per Employee	9,859
Employee Count	2,500
Asset Turnover	0.66
Inventory Turnover	1.62

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -32.82% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-32.82%
50-Day Moving Average	62.19
200-Day Moving Average	70.95
Relative Strength Index (RSI)	48.70
Average Volume (20 Days)	136,449

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, EI- Nile Co. for Pharmaceuticals and Chemical Industries had revenue of EGP 885.62 million and earned 24.65 million in profits. Earnings per share was 2.43.

Revenue	885.62M
Gross Profit	177.88M
Operating Income	73.87M
Pretax Income	26.46M
Net Income	24.65M
EBITDA	84.57M
EBIT	73.87M
Earnings Per Share (EPS)	2.43

Full Income Statement

Balance Sheet

The company has 17.71 million in cash and 505.39 million in debt, giving a net cash position of -487.68 million or -48.17 per share.

Cash & Cash Equivalents	17.71M
Total Debt	505.39M
Net Cash	-487.68M
Net Cash Per Share	-48.17
Equity (Book Value)	457.12M
Book Value Per Share	45.15
Working Capital	76.38M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 247.51 million and capital expenditures -503.59 million, giving a free cash flow of -256.08 million.

Operating Cash Flow	247.51M
Capital Expenditures	-503.59M
Free Cash Flow	-256.08M
FCF Per Share	-25.29

Full Cash Flow Statement

Margins

Gross margin is 20.08%, with operating and profit margins of 8.34% and 2.78%.

Gross Margin	20.08%
Operating Margin	8.34%
Pretax Margin	2.99%
Profit Margin	2.78%
EBITDA Margin	9.55%
EBIT Margin	8.34%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 3.71, which amounts to a dividend yield of 6.65%.

Dividend Per Share	3.71
Dividend Yield	6.65%
Dividend Growth (YoY)	-25.80%
Years of Dividend Growth	3
Payout Ratio	261.23%
Buyback Yield	n/a
Shareholder Yield	6.65%
Earnings Yield	4.36%
FCF Yield	-45.30%

Dividend Details

Stock Splits

The last stock split was on January 20, 2011. It was a forward split with a ratio of 1.5.

Last Split Date	Jan 20, 2011
Split Type	Forward
Split Ratio	1.5

Scores

EI- Nile Co. for Pharmaceuticals and Chemical Industries has an Altman Z-Score of 1.49. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.49
Piotroski F-Score	n/a